FDA Approved: CARDENE IV — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

The FDA approved a supplemental application for Cardene IV, a new intravenous formulation of nicardipine hydrochloride by Baxter Healthcare Corporation. The sup…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Hypertension

Drugs mentioned

• CARDENE IV (nicardipine hydrochloride)

Snippet

SUPPL AP for CARDENE IV (NICARDIPINE HYDROCHLORIDE)